Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jiang

Showing results (351-360 of 359) with videos related to

Pageof 36
Sort By:
You have reached the last page of results.This site can display upto 359 results.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|May 13, 2020
[Efficacy of minimally invasive pulmonary surfactant administration in preterm infants with neonatal respiratory distress syndrome: a multicenter clinical trial]H Q Liu, X M Tong, T Y Han, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Sex-Specific Skeletal Muscle Gene Expression Responses to Exercise Reveal Novel Direct Mediators of Insulin Sensitivity ChangeS Ma, M C Morris, M J Hubal, et al.
Oncogenesis|November 17, 2018
ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapyV L Veenstra, H Damhofer, C Waasdorp, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|November 26, 2025
[Long-term survival outcomes and prognostic factors following radical resection of pancreatic body and tail cancer:a retrospective analysis of 992 patients]D Xu, Y Wu, K Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2026
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trialT K Choueiri, L Albigès, D F McDermott, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2024
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 8-year follow-up results of efficacy and safety from the phase III CheckMate 214 trialN M Tannir, L Albigès, D F McDermott, et al.
Science (New York, N.Y.)|July 14, 2001
Haplotype variation and linkage disequilibrium in 313 human genesJ C Stephens, J A Schneider, D A Tanguay, et al.
Nature Biomedical Engineering|July 9, 2021
Biomaterial vaccines capturing pathogen-associated molecular patterns protect against bacterial infections and septic shockMichael Super, Edward J Doherty, Mark J Cartwright, et al.
Cancer Discovery|June 20, 2024
CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling AxisSunil Acharya, Rafet Basar, May Daher, et al.
Pageof 36

Showing results (351-360 of 359) with videos related to

Sort By:
Pageof 36
You have reached the last page of results.This site can display upto 359 results.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|May 13, 2020
[Efficacy of minimally invasive pulmonary surfactant administration in preterm infants with neonatal respiratory distress syndrome: a multicenter clinical trial]H Q Liu, X M Tong, T Y Han, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Sex-Specific Skeletal Muscle Gene Expression Responses to Exercise Reveal Novel Direct Mediators of Insulin Sensitivity ChangeS Ma, M C Morris, M J Hubal, et al.
Oncogenesis|November 17, 2018
ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapyV L Veenstra, H Damhofer, C Waasdorp, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|November 26, 2025
[Long-term survival outcomes and prognostic factors following radical resection of pancreatic body and tail cancer:a retrospective analysis of 992 patients]D Xu, Y Wu, K Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2026
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trialT K Choueiri, L Albigès, D F McDermott, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2024
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 8-year follow-up results of efficacy and safety from the phase III CheckMate 214 trialN M Tannir, L Albigès, D F McDermott, et al.
Science (New York, N.Y.)|July 14, 2001
Haplotype variation and linkage disequilibrium in 313 human genesJ C Stephens, J A Schneider, D A Tanguay, et al.
Nature Biomedical Engineering|July 9, 2021
Biomaterial vaccines capturing pathogen-associated molecular patterns protect against bacterial infections and septic shockMichael Super, Edward J Doherty, Mark J Cartwright, et al.
Cancer Discovery|June 20, 2024
CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling AxisSunil Acharya, Rafet Basar, May Daher, et al.
Pageof 36